Circulating biomarker results from a phase 2 study of seralutinib in pulmonary arterial hypertension
American Journal of Respiratory and Critical Care Medicine | May 7, 2026 | Volume: 212 | Issue: 8 | Pages: 1832-1837
10.1093/ajrccm/aamag175
| PMID 42104009